{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:38:58Z","timestamp":1782848338150,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.semarthrit.2013.05.004","type":"journal-article","created":{"date-parts":[[2013,12,8]],"date-time":"2013-12-08T15:25:39Z","timestamp":1386516339000},"page":"367-375","source":"Crossref","is-referenced-by-count":70,"title":["A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout"],"prefix":"10.1016","volume":"43","author":[{"given":"Labib I.","family":"Faruque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Ehteshami-Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Wiebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Tjosvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Homik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2A","key":"10.1016\/j.semarthrit.2013.05.004_bib1","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1016\/S0002-9343(97)89546-0","article-title":"Crystal-induced arthritis: an overview","volume":"100","author":"Schumacher","year":"1996","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.semarthrit.2013.05.004_bib2","first-page":"ii2","article-title":"New insights into the epidemiology of gout","volume":"48","author":"Doherty","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.05.004_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/ar2509","article-title":"Developments in the scientific and clinical understanding of gout","volume":"10","author":"So","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2013.05.004_bib4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2165\/00003495-200666120-00002","article-title":"Pathophysiology, clinical presentation and treatment of gout","volume":"66","author":"Teng","year":"2006","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.05.004_bib5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11926-004-0075-3","article-title":"Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase","volume":"6","author":"Bomalaski","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2013.05.004_bib6","unstructured":"Cohen MG, Emmerson BT. Chapter 12: Gout. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby; 1994. p. 1\u201316."},{"issue":"21","key":"10.1016\/j.semarthrit.2013.05.004_bib7","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","article-title":"Management of acute and chronic gouty arthritis: present state-of-the-art","volume":"64","author":"Schlesinger","year":"2004","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.05.004_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11926-010-0093-2","article-title":"New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond","volume":"12","author":"Schlesinger","year":"2010","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.05.004_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clindermatol.2006.07.015","article-title":"Metabolic diseases: gout","volume":"24","author":"Falasca","year":"2006","journal-title":"Clin Dermatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.05.004_bib10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3810\/pgm.2011.05.2284","article-title":"Managing your patient with gout: a review of treatment options","volume":"123","author":"Doghramji","year":"2011","journal-title":"Postgrad Med J"},{"issue":"Suppl. 1","key":"10.1016\/j.semarthrit.2013.05.004_bib11","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar1909","article-title":"Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics","volume":"8","author":"Terkeltaub","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2013.05.004_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3949\/ccjm.77a.09080","article-title":"Managing gout: how is it different in patients with chronic kidney disease?","volume":"77","author":"El-Zawawy","year":"2010","journal-title":"Cleve Clin J Med"},{"issue":"9760","key":"10.1016\/j.semarthrit.2013.05.004_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(10)60665-4","article-title":"Gout therapeutics: new drugs for an old disease","volume":"377","author":"Burns","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.05.004_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrrheum.2009.236","article-title":"Update on gout: new therapeutic strategies and options","volume":"6","author":"Terkeltaub","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.05.004_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/BOR.0b013e328325bd94","article-title":"Update on emerging urate-lowering therapies","volume":"21","author":"Chohan","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 2","key":"10.1016\/j.semarthrit.2013.05.004_bib16","first-page":"ii15","article-title":"Febuxostat: a new treatment for hyperuricaemia in gout","volume":"48","author":"Edwards","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.05.004_bib17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.05.004_bib18","first-page":"1381","article-title":"Outcome evaluations in gout","volume":"34","author":"Schumacher","year":"2007","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.05.004_bib19","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.3899\/jrheum.090370","article-title":"Outcome domains for studies of acute and chronic gout","volume":"36","author":"Schumacher","year":"2009","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2013.05.004_bib20","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/rheumatology\/kem178","article-title":"Assessment of outcome in clinical trials of gout\u2014a review of current measures","volume":"46","author":"Taylor","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"23","key":"10.1016\/j.semarthrit.2013.05.004_bib21","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2013.05.004_bib22","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/keg402","article-title":"Near-iron deficiency-induced remission of gouty arthritis","volume":"42","author":"Facchini","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.05.004_bib23","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares: analysis from managed care data","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2013.05.004_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23007","article-title":"Lowering serum uric acid levels: what is the optimal target for improving clinical outcomes in gout?","volume":"57","author":"Perez-Ruiz","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.semarthrit.2013.05.004_bib25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3899\/jrheum.110271","article-title":"Patient-reported outcomes in chronic gout: a report from OMERACT 10","volume":"38","author":"Singh","year":"2011","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.05.004_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/ard.2010.139899","article-title":"Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide","volume":"70","author":"Dalbeth","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2013.05.004_bib27","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.110272","article-title":"Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research priorities","volume":"38","author":"Dalbeth","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.05.004_bib28","unstructured":"Bionichepharma. Aloprim (allopurinol sodium) for injection. Product information 005863, \u3008http:\/\/www.bionichepharmausa.com\/pdf\/aloprim.pdf\u3009."},{"key":"10.1016\/j.semarthrit.2013.05.004_bib29","series-title":"Cochrane handbook for systematic reviews of interventions: the Cochrane Collaboration","article-title":"Chapter 6: Searching for studies","author":"Lefebvre","year":"2011"},{"key":"10.1016\/j.semarthrit.2013.05.004_bib30","series-title":"Cochrane handbook for systematic reviews of interventions: the Cochrane Collaboration","article-title":"Chapter 8: Assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.05.004_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jclinepi.2005.08.017","article-title":"A systematic review identifies a lack of standardization in methods for handling missing variance data","volume":"59","author":"Wiebe","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"7414","key":"10.1016\/j.semarthrit.2013.05.004_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.05.004_bib33","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar2978","article-title":"The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial","volume":"12","author":"Becker","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"4 Suppl. 2","key":"10.1016\/j.semarthrit.2013.05.004_bib34","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/RHU.0b013e31821d36cc","volume":"17","author":"Kamatani","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"4 Suppl. 2","key":"10.1016\/j.semarthrit.2013.05.004_bib35","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/RHU.0b013e31821d352f","volume":"17","author":"Naoyuki","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.semarthrit.2013.05.004_bib36","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.05.004_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3329\/bjms.v10i4.7522","article-title":"Comparison between allopurinol and febuxostat in management of gout patients\u2013a prospective study","volume":"10","author":"Singal","year":"2011","journal-title":"Bangladesh J Med Sci"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.05.004_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.080814","article-title":"Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout","volume":"36","author":"Becker","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2013.05.004_bib39","unstructured":"FDA. Name of drug: Uloric. Indication: management of hyperuricemia in patients with gout. Centre for Drug evaluation and Research. Food and Drug Administration; 2009 [Contract no.: NDA 21-856\/N0046]."},{"key":"10.1016\/j.semarthrit.2013.05.004_bib40","unstructured":"EMA. CHMP assessment report for adenuric. European Medicines Agency; 2008 [Contract no.: EMEA\/258531\/2008]."},{"issue":"14","key":"10.1016\/j.semarthrit.2013.05.004_bib41","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.clinthera.2011.01.008","article-title":"Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials","volume":"32","author":"Wortmann","year":"2010","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.05.004_bib42","article-title":"Oral urate lowering therapies in chronic gout: a systematic review and meta-analysis","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.05.004_bib43","first-page":"608","article-title":"Febuxostat for the treatment of chronic recurrent gout: a meta-analysis","volume":"69","author":"Lopez-Olivo","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.05.004_bib44","first-page":"687","article-title":"Febuxostat versus allopurinol for hyperuricemia and gout: a meta-analysis (Fame study)","volume":"70","author":"Lo","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.05.004_bib45","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017213000838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017213000838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T17:10:12Z","timestamp":1564938612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017213000838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0049017213000838"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2013.05.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}